Page last updated: 2024-09-05

orbofiban and arginyl-glycyl-aspartic acid

orbofiban has been researched along with arginyl-glycyl-aspartic acid in 1 studies

Compound Research Comparison

Studies
(orbofiban)
Trials
(orbofiban)
Recent Studies (post-2010)
(orbofiban)
Studies
(arginyl-glycyl-aspartic acid)
Trials
(arginyl-glycyl-aspartic acid)
Recent Studies (post-2010) (arginyl-glycyl-aspartic acid)
481704,556171,799

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adderley, SR; Fitzgerald, DJ1

Other Studies

1 other study(ies) available for orbofiban and arginyl-glycyl-aspartic acid

ArticleYear
Glycoprotein IIb/IIIa antagonists induce apoptosis in rat cardiomyocytes by caspase-3 activation.
    The Journal of biological chemistry, 2000, Feb-25, Volume: 275, Issue:8

    Topics: Alanine; Animals; Apoptosis; Benzamidines; Caspase 3; Caspases; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium; Enzyme Activation; Enzyme Precursors; Eptifibatide; Humans; Kinetics; Ligands; Mice; Myocardium; Oligopeptides; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Rats; Rats, Wistar; Time Factors; Umbilical Veins

2000